360PSystemic therapy in second-line metastatic triple negative breast cancer (mTNBC): A systematic literature review (SLR) and meta-analysis (MA) of efficacy

Abstract Background Triple negative breast cancer carries a poor prognosis. Cytotoxic chemotherapy (chemo) is the standard of care. Recent data demonstrate that immunotherapy and anti-body drug conjugate based therapy can improve outcomes. Nevertheless survival remains poor. This SLR and MA was perf...

Full description

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 30; no. Supplement_5
Main Authors Kaufman, P A, Kwon, C S, Feliciano, J, Westley, T, Forsythe, A, Garfin, P, Brown, L
Format Journal Article
LanguageEnglish
Published Oxford University Press 01.10.2019
Online AccessGet full text

Cover

Loading…